{
"NDC": [
{
"NDCCode": "50845-0238-2",
"PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (50845-0238-2) > 30 mL in 1 BOTTLE, DROPPER (50845-0238-1) ",
"NDC11Code": "50845-0238-02",
"ProductNDC": "50845-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Vaccines",
"NonProprietaryName": "Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20180306",
"EndMarketingDate": "20250212",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ARNICA MONTANA; MERCURIC CHLORIDE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAF; URTICA URENS",
"StrengthNumber": "3; 200; 200; 200; 3",
"StrengthUnit": "[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2025-02-13",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20180306",
"EndMarketingDatePackage": "20250212",
"SamplePackage": "N",
"IndicationAndUsage": "May temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. Children and adults may expect temporary relief from symptoms such as. minor fever. pain. redness. weakness. lack of energy. swelling**. **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."
},
{
"NDCCode": "50845-0238-1",
"PackageDescription": "30 mL in 1 BOTTLE, DROPPER (50845-0238-1) ",
"NDC11Code": "50845-0238-01",
"ProductNDC": "50845-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Vaccines",
"NonProprietaryName": "Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20180306",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ARNICA MONTANA; MERCURIC CHLORIDE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAF; URTICA URENS",
"StrengthNumber": "3; 200; 200; 200; 3",
"StrengthUnit": "[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2018-04-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20191231",
"StartMarketingDatePackage": "20180306",
"SamplePackage": "N"
},
{
"NDCCode": "15631-0238-2",
"PackageDescription": "400 PELLET in 1 PACKAGE (15631-0238-2) ",
"NDC11Code": "15631-0238-02",
"ProductNDC": "15631-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Iridium Metallicum",
"NonProprietaryName": "Iridium Metallicum",
"DosageFormName": "PELLET",
"RouteName": "ORAL",
"StartMarketingDate": "20150902",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Rxhomeo Private Limited d.b.a. Rxhomeo, Inc",
"SubstanceName": "IRIDIUM",
"StrengthNumber": "3",
"StrengthUnit": "[hp_X]/1",
"Status": "Deprecated",
"LastUpdate": "2022-01-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20211231",
"StartMarketingDatePackage": "20180101",
"SamplePackage": "N",
"IndicationAndUsage": "Condition listed above or as directed by the physician."
},
{
"NDCCode": "17856-0238-2",
"PackageDescription": "60 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0238-2) / 2.5 mL in 1 CUP, UNIT-DOSE",
"NDC11Code": "17856-0238-02",
"ProductNDC": "17856-0238",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Morphine Sulfate",
"NonProprietaryName": "Morphine Sulfate",
"DosageFormName": "SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20080317",
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA022195",
"LabelerName": "ATLANTIC BIOLOGICALS CORP.",
"SubstanceName": "MORPHINE SULFATE",
"StrengthNumber": "20",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Full Opioid Agonists [MoA], Opioid Agonist [EPC]",
"DEASchedule": "CII",
"Status": "Deprecated",
"LastUpdate": "2026-01-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20240520",
"SamplePackage": "N",
"IndicationAndUsage": "Morphine sulfate solution are formulations of morphine, an opioid agonist, indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. Morphine sulfate solution is an opioid analgesic indicated for the relief of moderate to severe acute and chronic pain in opioid-tolerant patients. oral(10 mg per 5 mL and 20 mg per 5 mL)oral100 mg per 5 mL (20 mg/mL). Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL) may cause fatal respiratory depression when administered to patients not previously exposed to opioids. Patients considered to be opioid tolerant are those who are taking at least 60 mg oral morphine per day, or at least 30 mg of oral oxycodone per day, or at least 12 mg hydromorphone per day, or an equianalgesic dose of another opioid, for a week or longer.",
"Description": "Chemically, morphine sulfate is 7,8-didehydro-4,5 alpha-epoxy-17 methyl-morphinan-3,6 alpha-diol sulfate (2:1) (salt) pentahydrate with a molecular mass of 758. Morphine sulfate occurs as white, feathery, silky crystals; cubical masses of crystal; or white crystalline powder. It is soluble in water anlightly soluble in alcohol, but is practically insoluble in chloroform or ether. The octanol:water partition coefficient of morphine is 1.42 at physiologic pH and the pKa is 7.9 for the tertiary nitrogen (the majority is ionized at pH 7.4). For the 10 mg and 20 mg per 5 mL strengths: Each 5 mL of oral solution contains 10 or 20 mg of morphine sulfate USP and the following inactive ingredients: citric acid, edetate disodium, FD&C Green No. 3 (fast green), glycerin, methylparaben (only in 20 mg/5 mL concentration), propylparaben (only in 20 mg/5 mL concentration), sodium benzoate, sorbitol and water. For the 100 mg per 5 mL (20 mg/mL) strength: Each 5 mL of oral solution contains 100 mg of morphine sulfate USP and the following inactive ingredients: citric acid, edetate disodium, glycerin, sodium benzoate, sorbitol, and water. Additionally, the tinted solution contains D & C Red No. 33 and sucralose."
},
{
"NDCCode": "37662-0238-2",
"PackageDescription": "500 PELLET in 1 VIAL, GLASS (37662-0238-2) ",
"NDC11Code": "37662-0238-02",
"ProductNDC": "37662-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Chelidonium Majus",
"NonProprietaryName": "Chelidonium Majus",
"DosageFormName": "PELLET",
"RouteName": "ORAL",
"StartMarketingDate": "20220531",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Hahnemann Laboratories, INC.",
"SubstanceName": "CHELIDONIUM MAJUS",
"StrengthNumber": "200",
"StrengthUnit": "[hp_C]/1",
"Status": "Active",
"LastUpdate": "2022-06-02",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20220531",
"SamplePackage": "N"
},
{
"NDCCode": "49288-0238-1",
"PackageDescription": "2 mL in 1 VIAL, MULTI-DOSE (49288-0238-1)",
"NDC11Code": "49288-0238-01",
"ProductNDC": "49288-0238",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Number Fourteen Grass Mixture",
"NonProprietaryName": "Number Fourteen Grass Mixture",
"DosageFormName": "INJECTION, SOLUTION",
"RouteName": "INTRADERMAL; SUBCUTANEOUS",
"StartMarketingDate": "19970613",
"MarketingCategoryName": "BLA",
"ApplicationNumber": "BLA102223",
"LabelerName": "Antigen Laboratories, Inc.",
"SubstanceName": "POA COMPRESSA POLLEN; TYPHA LATIFOLIA POLLEN; BROMUS SECALINUS POLLEN; ZEA MAYS POLLEN; SECALE CEREALE POLLEN; TRITICUM AESTIVUM POLLEN; SORGHUM HALEPENSE POLLEN; ELYMUS REPENS POLLEN; PHALARIS ARUNDINACEA POLLEN; BROMUS INERMIS POLLEN; SORGHUM BICOLOR SSP. DRUMMONDII POLLEN; ARRHENATHERUM ELATIUS POLLEN; HOLCUS LANATUS POLLEN; PASCOPYRUM SMITHII POLLEN",
"StrengthNumber": ".0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036",
"StrengthUnit": "g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL",
"Pharm_Classes": "Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]",
"Status": "Deprecated",
"LastUpdate": "2019-09-21",
"ProductNdcExcludeFlag": "E",
"ListingRecordCertifiedThrough": "20171231",
"IndicationAndUsage": "Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.",
"Description": "Antigen Laboratories’ allergenic extracts are manufactured from source material listed on the vial label. Lower concentrations (e.g. 1:50, 1:33, etc.) may be prepared either by dilution from a more concentrated stock or by direct extraction. The extract is a sterile solution containing extractables of source materials obtained from biological collecting and/or processing firms and Antigen Laboratories. All source materials are inspected by Antigen Laboratories’ technical personnel in accordance with 21 CFR 680.1 (b) (1). The route of administration for immunotherapy is subcutaneous. The routes of administration for diagnostic purposes are intradermal or prick-puncture of the skin. FOR ALLERGENIC EXTRACTS CONTAINING 50% V/V GLYCERINE AS PRESERVATIVE AND STABILIZER. INACTIVE INGREDIENTS. Sodium chloride…………………………………………………………….0.95%. Sodium bicarbonate………………………………………………………..0.24%. Glycerine…………………………………………………………………50% (v/v). Water for Injection…………………………………………………q.s. to volume. Active allergens are described by common and scientific name on the stock concentrate container label or on last page of this circular. Food allergenic extracts may be manufactured on a weight/volume (w/v) or volume/volume (v/v) basis. Food extracts made from dried raw material are extracted at 2-10% (1:50-1:10 w/v ratio) in extracting fluid containing 50% glycerine. Slurries of juicy fruits or vegetables (prepared with a minimum amount of water for injection) are combined with an equal volume of glycerine for a ration of 1:1 volume/volume (v/v). Sodium chloride and sodium bicarbonate are added to the slurry and glycerine mixture. Fresh egg white extract is prepared by adding one part raw egg white to nine parts of extracting fluid (1:9 v/v). Antigen E is considered the most important allergen of Short Ragweed pollen and is used for the standardization of Short Ragweed allergenic extracts. Stock mixtures containing Short Ragweed are analyzed for Antigen E content by radial immunodiffusion using Center for Biologics Evaluation and Research (CBER) references and anti-serum. Antigen E content expressed as units of Antigen E per milliliter (U/ml) is printed on container label."
},
{
"NDCCode": "49288-0238-2",
"PackageDescription": "5 mL in 1 VIAL, MULTI-DOSE (49288-0238-2)",
"NDC11Code": "49288-0238-02",
"ProductNDC": "49288-0238",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Number Fourteen Grass Mixture",
"NonProprietaryName": "Number Fourteen Grass Mixture",
"DosageFormName": "INJECTION, SOLUTION",
"RouteName": "INTRADERMAL; SUBCUTANEOUS",
"StartMarketingDate": "19970613",
"MarketingCategoryName": "BLA",
"ApplicationNumber": "BLA102223",
"LabelerName": "Antigen Laboratories, Inc.",
"SubstanceName": "POA COMPRESSA POLLEN; TYPHA LATIFOLIA POLLEN; BROMUS SECALINUS POLLEN; ZEA MAYS POLLEN; SECALE CEREALE POLLEN; TRITICUM AESTIVUM POLLEN; SORGHUM HALEPENSE POLLEN; ELYMUS REPENS POLLEN; PHALARIS ARUNDINACEA POLLEN; BROMUS INERMIS POLLEN; SORGHUM BICOLOR SSP. DRUMMONDII POLLEN; ARRHENATHERUM ELATIUS POLLEN; HOLCUS LANATUS POLLEN; PASCOPYRUM SMITHII POLLEN",
"StrengthNumber": ".0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036",
"StrengthUnit": "g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL",
"Pharm_Classes": "Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]",
"Status": "Deprecated",
"LastUpdate": "2019-09-21",
"ProductNdcExcludeFlag": "E",
"ListingRecordCertifiedThrough": "20171231",
"IndicationAndUsage": "Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.",
"Description": "Antigen Laboratories’ allergenic extracts are manufactured from source material listed on the vial label. Lower concentrations (e.g. 1:50, 1:33, etc.) may be prepared either by dilution from a more concentrated stock or by direct extraction. The extract is a sterile solution containing extractables of source materials obtained from biological collecting and/or processing firms and Antigen Laboratories. All source materials are inspected by Antigen Laboratories’ technical personnel in accordance with 21 CFR 680.1 (b) (1). The route of administration for immunotherapy is subcutaneous. The routes of administration for diagnostic purposes are intradermal or prick-puncture of the skin. FOR ALLERGENIC EXTRACTS CONTAINING 50% V/V GLYCERINE AS PRESERVATIVE AND STABILIZER. INACTIVE INGREDIENTS. Sodium chloride…………………………………………………………….0.95%. Sodium bicarbonate………………………………………………………..0.24%. Glycerine…………………………………………………………………50% (v/v). Water for Injection…………………………………………………q.s. to volume. Active allergens are described by common and scientific name on the stock concentrate container label or on last page of this circular. Food allergenic extracts may be manufactured on a weight/volume (w/v) or volume/volume (v/v) basis. Food extracts made from dried raw material are extracted at 2-10% (1:50-1:10 w/v ratio) in extracting fluid containing 50% glycerine. Slurries of juicy fruits or vegetables (prepared with a minimum amount of water for injection) are combined with an equal volume of glycerine for a ration of 1:1 volume/volume (v/v). Sodium chloride and sodium bicarbonate are added to the slurry and glycerine mixture. Fresh egg white extract is prepared by adding one part raw egg white to nine parts of extracting fluid (1:9 v/v). Antigen E is considered the most important allergen of Short Ragweed pollen and is used for the standardization of Short Ragweed allergenic extracts. Stock mixtures containing Short Ragweed are analyzed for Antigen E content by radial immunodiffusion using Center for Biologics Evaluation and Research (CBER) references and anti-serum. Antigen E content expressed as units of Antigen E per milliliter (U/ml) is printed on container label."
},
{
"NDCCode": "59535-0238-2",
"PackageDescription": "5 POUCH in 1 PACKAGE (59535-0238-2) > 20 g in 1 POUCH (59535-0238-1)",
"NDC11Code": "59535-0238-02",
"ProductNDC": "59535-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Volcanic Grape Callus Mask",
"NonProprietaryName": "Adenosine, Niacinamide",
"DosageFormName": "LIQUID",
"RouteName": "TOPICAL",
"StartMarketingDate": "20160801",
"MarketingCategoryName": "UNAPPROVED DRUG OTHER",
"LabelerName": "AMI Cosmetic Co.,Ltd.",
"SubstanceName": "NIACINAMIDE; ADENOSINE",
"StrengthNumber": "2; .04",
"StrengthUnit": "g/100g; g/100g",
"Status": "Deprecated",
"LastUpdate": "2019-01-18",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20191231"
},
{
"NDCCode": "62011-0238-2",
"PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (62011-0238-2) / 24 TABLET, COATED in 1 BOTTLE, PLASTIC",
"NDC11Code": "62011-0238-02",
"ProductNDC": "62011-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Pain Reliever Rapid Release",
"NonProprietaryName": "Acetaminophen",
"DosageFormName": "TABLET, COATED",
"RouteName": "ORAL",
"StartMarketingDate": "20141024",
"EndMarketingDate": "20260131",
"MarketingCategoryName": "OTC MONOGRAPH DRUG",
"ApplicationNumber": "M013",
"LabelerName": "Strategic Sourcing Services LLC",
"SubstanceName": "ACETAMINOPHEN",
"StrengthNumber": "500",
"StrengthUnit": "mg/1",
"Status": "Deprecated",
"LastUpdate": "2026-02-02",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20180301",
"EndMarketingDatePackage": "20260131",
"SamplePackage": "N",
"IndicationAndUsage": "temporarily relieves minor aches and pains due to: the common coldheadachebackacheminor pain of arthritistoothachemuscular achespremenstrual and menstrual cramps. temporarily reduces fever."
},
{
"NDCCode": "66406-0238-2",
"PackageDescription": "24 BOTTLE in 1 CASE (66406-0238-2) > 90 CAPSULE in 1 BOTTLE",
"NDC11Code": "66406-0238-02",
"ProductNDC": "66406-0238",
"ProductTypeName": "DRUG FOR FURTHER PROCESSING",
"NonProprietaryName": "Droxidopa",
"DosageFormName": "CAPSULE",
"StartMarketingDate": "20140901",
"EndMarketingDate": "20180117",
"MarketingCategoryName": "DRUG FOR FURTHER PROCESSING",
"LabelerName": "Patheon Inc.",
"SubstanceName": "DROXIDOPA",
"StrengthNumber": "100",
"StrengthUnit": "mg/1",
"Status": "Deprecated",
"LastUpdate": "2014-02-04",
"ListingRecordCertifiedThrough": "20180117"
},
{
"NDCCode": "67296-0238-2",
"PackageDescription": "15 TABLET in 1 BOTTLE (67296-0238-2) ",
"NDC11Code": "67296-0238-02",
"ProductNDC": "67296-0238",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Prochlorperazine Maleate",
"NonProprietaryName": "Prochlorperazine Maleate",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20010101",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA040268",
"LabelerName": "RedPharm Drug, Inc.",
"SubstanceName": "PROCHLORPERAZINE MALEATE",
"StrengthNumber": "10",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Phenothiazine [EPC], Phenothiazines [CS]",
"Status": "Deprecated",
"LastUpdate": "2026-01-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20010101",
"SamplePackage": "N",
"IndicationAndUsage": "For control of severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. However, prochlorperazine is not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). When used in the treatment of non-psychotic anxiety, prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see WARNINGS). The effectiveness of prochlorperazine as treatment for non-psychotic anxiety was established in 4-week clinical studies of outpatients with generalized anxiety disorder. This evidence does not predict that prochlorperazine will be useful in patients with other non-psychotic conditions in which anxiety, or signs that mimic anxiety, are found (e.g., physical illness, organic mental conditions, agitated depression, character pathologies, etc.). Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.",
"Description": "Prochlorperazine is a phenothiazine derivative, present in prochlorperazine tablets as the maleate. Prochlorperazine maleate is designated chemically as 2-chloro-10-[3-(4- methyl-1 -piperazinyl)propyl] phenothiazine maleate [molecular weight 606.10] and has the following structure. [Structure of Prochlorperazine]. Prochlorperazine Maleate is classified as an anti-emetic and antipsychotic agent. Prochlorperazine maleate is white or pale yellow, practically odorless crystalline powder. It is practically insoluble in water and in alcohol; slightly soluble in warm chloroform. Each tablet, for oral administration contains prochlorperazine maleate equivalent to 5 mg or 10 mg of prochlorperazine. In addition, each tablet contains the following inactive ingredients: D&C yellow no. 10 aluminum lake, FD&C blue no. 2 aluminum lake, FD&C yellow no. 6 aluminum lake, hydroxypropyl methylcellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, pregelatinized starch, stearic acid and titanium dioxide."
},
{
"NDCCode": "70518-0238-2",
"PackageDescription": "30 CAPSULE in 1 BOTTLE, PLASTIC (70518-0238-2) ",
"NDC11Code": "70518-0238-02",
"ProductNDC": "70518-0238",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Clindamycin Hydrochloride",
"NonProprietaryName": "Clindamycin Hydrochloride",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20170220",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA063029",
"LabelerName": "REMEDYREPACK INC.",
"SubstanceName": "CLINDAMYCIN HYDROCHLORIDE",
"StrengthNumber": "300",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]",
"Status": "Deprecated",
"LastUpdate": "2019-12-24",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20201231",
"StartMarketingDatePackage": "20170419",
"SamplePackage": "N"
},
{
"NDCCode": "71335-0238-2",
"PackageDescription": "60 TABLET in 1 BOTTLE (71335-0238-2) ",
"NDC11Code": "71335-0238-02",
"ProductNDC": "71335-0238",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Citalopram Hydrobromide",
"NonProprietaryName": "Citalopram Hydrobromide",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20071018",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA078216",
"LabelerName": "Bryant Ranch Prepack",
"SubstanceName": "CITALOPRAM HYDROBROMIDE",
"StrengthNumber": "20",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]",
"Status": "Active",
"LastUpdate": "2024-11-13",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20180919",
"SamplePackage": "N",
"IndicationAndUsage": "Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14)] .",
"Description": "Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (±)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3dihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula. The molecular formula is C 20H 22BrFN 2O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder. Citalopram hydrobromide is sparingly soluble in water and soluble in ethanol. Citalopram, USP 10 mg tablets are film-coated, round shaped tablets containing citalopram hydrobromide in strengths equivalent to 10 mg citalopram base. Citalopram hydrobromide, USP 20 mg and 40 mg tablets are film-coated, oval shaped, scored tablets containing citalopram hydrobromide, in strengths equivalent to 20 mg or 40 mg citalopram base. The tablets also contain the following inactive ingredients: copovidone, corn starch, croscarmellose sodium, ferric oxide red, ferric oxide yellow, glycerin, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, and titanium dioxide."
},
{
"NDCCode": "79481-0238-2",
"PackageDescription": "118 mL in 1 BOTTLE, PLASTIC (79481-0238-2) ",
"NDC11Code": "79481-0238-02",
"ProductNDC": "79481-0238",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Oil-free Moisturizer",
"NonProprietaryName": "Avobenzone, Octisalate, Octocrylene",
"DosageFormName": "LOTION",
"RouteName": "TOPICAL",
"StartMarketingDate": "20200315",
"MarketingCategoryName": "OTC MONOGRAPH DRUG",
"ApplicationNumber": "M020",
"LabelerName": "Meijer Distribution, Inc.",
"SubstanceName": "AVOBENZONE; OCTISALATE; OCTOCRYLENE",
"StrengthNumber": "30; 50; 50",
"StrengthUnit": "mg/mL; mg/mL; mg/mL",
"Status": "Deprecated",
"LastUpdate": "2025-04-18",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20200315",
"SamplePackage": "N",
"IndicationAndUsage": "■ helps prevent sunburn ■ if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun."
},
{
"NDCCode": "50845-0018-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (50845-0018-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0018-1)",
"NDC11Code": "50845-0018-02",
"ProductNDC": "50845-0018",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Acne",
"NonProprietaryName": "Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuratum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20110120",
"EndMarketingDate": "20190326",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; ANTIMONY TRISULFIDE; CENTELLA ASIATICA; JUGLANS REGIA FLOWERING TOP; POTASSIUM BROMIDE; LEDUM PALUSTRE TWIG; SODIUM SULFIDE NONAHYDRATE; RANCID BEEF; RADIUM BROMIDE; SANGUINARIA CANADENSIS ROOT; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS",
"StrengthNumber": "200; 30; 30; 6; 30; 6; 200; 30; 200; 3; 200; 200; 3",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2019-03-27",
"ProductNdcExcludeFlag": "N"
},
{
"NDCCode": "50845-0018-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0018-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0018-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0018-1)",
"NDC11Code": "50845-0018-03",
"ProductNDC": "50845-0018",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Acne",
"NonProprietaryName": "Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuratum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20110120",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; ANTIMONY TRISULFIDE; CENTELLA ASIATICA; JUGLANS REGIA FLOWERING TOP; POTASSIUM BROMIDE; LEDUM PALUSTRE TWIG; SODIUM SULFIDE NONAHYDRATE; RANCID BEEF; RADIUM BROMIDE; SANGUINARIA CANADENSIS ROOT; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS",
"StrengthNumber": "200; 30; 30; 6; 30; 6; 200; 30; 200; 3; 200; 200; 3",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2016-12-02"
},
{
"NDCCode": "50845-0021-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0021-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0021-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0021-1)",
"NDC11Code": "50845-0021-03",
"ProductNDC": "50845-0021",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Cough And Bronchial",
"NonProprietaryName": "Antimonium Tartaricum, Arsenicum Album, Arsenicum Iodatum, Arum Triphyllum, Baptisia Tinctoria, Bryonia, Drosera, Echinacea,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100902",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories",
"SubstanceName": "ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ARSENIC TRIIODIDE; ARISAEMA TRIPHYLLUM ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; ECHINACEA; EUPATORIUM PERFOLIATUM FLOWERING TOP; POTASSIUM BROMIDE; SUS SCROFA LUNG; MERCURIC CHLORIDE; LOBARIA PULMONARIA; SULFUR IODIDE; URTICA URENS",
"StrengthNumber": "200; 200; 200; 30; 3; 200; 30; 3; 200; 6; 6; 200; 200; 200; 200",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL",
"Status": "Deprecated",
"LastUpdate": "2019-02-06",
"ProductNdcExcludeFlag": "E",
"ListingRecordCertifiedThrough": "20171231"
},
{
"NDCCode": "50845-0031-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0031-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0031-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0031-1)",
"NDC11Code": "50845-0031-03",
"ProductNDC": "50845-0031",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Allergy",
"NonProprietaryName": "Allium Cepa, Apis Mellifica, Aralia Racemosa, Arundo Mauritanica, Baptisia Tinctoria, Echinacea, Euphrasia Officinalis, Gelsemium Sempervirens,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100812",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories",
"SubstanceName": "ONION; APIS MELLIFERA; ARALIA RACEMOSA ROOT; ARUNDO PLINIANA ROOT; BAPTISIA TINCTORIA ROOT; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; TOXICODENDRON PUBESCENS LEAF; SCHOENOCAULON OFFICINALE SEED; SANGUINARIA CANADENSIS ROOT; URTICA URENS",
"StrengthNumber": "6; 3; 6; 30; 3; 4; 6; 200; 12; 6; 200; 6; 200; 200",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL",
"Status": "Deprecated",
"LastUpdate": "2019-01-22",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20191231"
},
{
"NDCCode": "50845-0032-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (50845-0032-2) / 30 mL in 1 BOTTLE, SPRAY (50845-0032-1) ",
"NDC11Code": "50845-0032-02",
"ProductNDC": "50845-0032",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Jet Lag",
"NonProprietaryName": "Anacardium Orientale, Apis Mellifica, Carbo Vegetabilis, Carduus Marianus, Cocculus Indicus, Kali Phosphoricum, Nux Vomica, Passiflora Incarnata, Phosphoricum Acidum, Tabacum,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20110602",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "SEMECARPUS ANACARDIUM JUICE; APIS MELLIFERA; ACTIVATED CHARCOAL; SILYBUM MARIANUM SEED; ANAMIRTA COCCULUS SEED; POTASSIUM PHOSPHATE, DIBASIC; STRYCHNOS NUX-VOMICA SEED; PASSIFLORA INCARNATA TOP; PHOSPHORIC ACID; TOBACCO LEAF",
"StrengthNumber": "12; 200; 200; 3; 30; 12; 30; 1; 200; 6",
"StrengthUnit": "[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL",
"Pharm_Classes": "Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]",
"Status": "Active",
"LastUpdate": "2024-05-23",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20161101",
"SamplePackage": "N",
"IndicationAndUsage": "For use during and after jet travel as it may help temporarily relieve the symptoms commonly known as \"jet lag\", such as tiredness, feelings of disorientation, dehydration, and sleeplessness.**. **Claims based upon traditional homeopathic practice, not accepted medical evidence. Not FDA Evaluated."
},
{
"NDCCode": "50845-0032-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0032-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0032-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0032-1)",
"NDC11Code": "50845-0032-03",
"ProductNDC": "50845-0032",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Jet Lag",
"NonProprietaryName": "Anacardium Orientale, Apis Mellifica, Carbo Vegetabilis, Carduus Marianus, Cocculus Indicus, Kali Phosphoricum, Nux Vomica, Passiflora Incarnata, Phosphoricum Acidum, Tabacum,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20110602",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; APIS MELLIFERA; PASSIFLORA INCARNATA TOP; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SEMECARPUS ANACARDIUM JUICE; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF",
"StrengthNumber": "200; 30; 200; 1; 200; 12; 12; 3; 30; 6",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2015-01-16"
},
{
"NDCCode": "50845-0035-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (50845-0035-2) / 30 mL in 1 BOTTLE, SPRAY (50845-0035-1) ",
"NDC11Code": "50845-0035-02",
"ProductNDC": "50845-0035",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Vital Female Sexual Energy",
"NonProprietaryName": "Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Hypophysis Suis, L-arginine, Lactuca Virosa, Onosmodium Virginianum, Oophorinum Suis, Phosphoricum Acidum, Sepia, Thuja Occidentalis",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100810",
"EndMarketingDate": "20241221",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ARGININE; ARNICA MONTANA WHOLE; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; LACTUCA VIROSA WHOLE; ONOSMODIUM VIRGINIANUM WHOLE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND, POSTERIOR; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG",
"StrengthNumber": "6; 3; 6; 3; 3; 3; 30; 200; 30; 30; 12; 30; 1",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2024-12-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20160421",
"EndMarketingDatePackage": "20241221",
"SamplePackage": "N",
"IndicationAndUsage": "May temporarily relieve symptoms of low female sexual energy, which may include. decrease in sexual desire. decrease in responsiveness and enjoyment. feelings of fatigue**. **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration."
},
{
"NDCCode": "50845-0035-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0035-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0035-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0035-1)",
"NDC11Code": "50845-0035-03",
"ProductNDC": "50845-0035",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Vital Female Sexual Energy",
"NonProprietaryName": "Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Lactuca Virosa, L-arginine,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100810",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ARGININE; ARNICA MONTANA; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; LACTUCA VIROSA; ONOSMODIUM VIRGINIANUM WHOLE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG",
"StrengthNumber": "6; 3; 6; 3; 3; 3; 30; 200; 30; 30; 12; 30; 1",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2015-01-02"
},
{
"NDCCode": "50845-0038-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0038-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0038-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0038-1)",
"NDC11Code": "50845-0038-03",
"ProductNDC": "50845-0038",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Vital Male Sexual Energy",
"NonProprietaryName": "Arnica Montana, Caladium Seguinum, Carduus Marianus, Damiana, Galium Aparine, Glandula Suprarenalis Suis, Hepar Suis, Korean Ginseng,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100810",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc",
"SubstanceName": "ARNICA MONTANA; DIEFFENBACHIA SEGUINE; SILYBUM MARIANUM SEED; TURNERA DIFFUSA LEAFY TWIG; GALIUM APARINE; SUS SCROFA ADRENAL GLAND; PORK LIVER; ASIAN GINSENG; PHOSPHORIC ACID; SUS SCROFA PITUITARY GLAND; POPULUS TREMULOIDES BARK; TESTOSTERONE; THUJA OCCIDENTALIS LEAFY TWIG; SUS SCROFA THYMUS; SUS SCROFA THYROID; SUS SCROFA TESTICLE; LACTUCA VIROSA; NUPHAR LUTEUM ROOT",
"StrengthNumber": "3; 6; 3; 1; 3; 12; 6; 1; 200; 12; 1; 30; 200; 6; 12; 6; 3; 2",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2019-02-06",
"ProductNdcExcludeFlag": "E",
"ListingRecordCertifiedThrough": "20171231"
},
{
"NDCCode": "50845-0041-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0041-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0041-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0041-1)",
"NDC11Code": "50845-0041-03",
"ProductNDC": "50845-0041",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Vital Hgh",
"NonProprietaryName": "Hepar Suis, Human Growth Hormone, Pituitary Suis,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100812",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories",
"SubstanceName": "PORK LIVER; SOMATROPIN; SUS SCROFA PITUITARY GLAND",
"StrengthNumber": "6; 30; 30",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2019-02-06",
"ProductNdcExcludeFlag": "E",
"ListingRecordCertifiedThrough": "20171231"
},
{
"NDCCode": "50845-0042-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0042-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0042-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0042-1) ",
"NDC11Code": "50845-0042-03",
"ProductNDC": "50845-0042",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Brain Energy",
"NonProprietaryName": "Arnica Montana, Brain Suis, Carduus Marianus, Cinchona Officinalis, Gingko Biloba, Lecithin, Millefolium, Phosphoricum Acidum,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100928",
"EndMarketingDate": "20220930",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories",
"SubstanceName": "ACHILLEA MILLEFOLIUM; ARNICA MONTANA; CINCHONA OFFICINALIS BARK; EGG PHOSPHOLIPIDS; GINKGO; PHOSPHORIC ACID; PORK BRAIN; SILYBUM MARIANUM SEED",
"StrengthNumber": "3; 3; 6; 12; 6; 30; 6; 3",
"StrengthUnit": "[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2022-10-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20100928",
"EndMarketingDatePackage": "20220930",
"SamplePackage": "N"
},
{
"NDCCode": "50845-0043-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (50845-0043-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0043-1) ",
"NDC11Code": "50845-0043-02",
"ProductNDC": "50845-0043",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Anger",
"NonProprietaryName": "Aconitum Napellus, Asafoetida, Chamomilla, Crocus Sativus, Hyoscyamus Niger, Ignatia Amara, Sumbul, Valeriana Officinalis",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100825",
"EndMarketingDate": "20240321",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories",
"SubstanceName": "ACONITUM NAPELLUS; ASAFETIDA; FERULA SUMBUL ROOT; HYOSCYAMUS NIGER; MATRICARIA RECUTITA; SAFFRON; STRYCHNOS IGNATII SEED; VALERIAN",
"StrengthNumber": "200; 4; 3; 200; 3; 3; 4; 3",
"StrengthUnit": "[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2024-03-22",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20160526",
"EndMarketingDatePackage": "20240321",
"SamplePackage": "N",
"IndicationAndUsage": "May temporarily relieve symptoms of anger, such as: 1 explosive outbursts, 2 feelings of hostility, 3 restlessness, 4 irritability."
},
{
"NDCCode": "50845-0043-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0043-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0043-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0043-1)",
"NDC11Code": "50845-0043-03",
"ProductNDC": "50845-0043",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Anger",
"NonProprietaryName": "Aconitum Napellus, Asafoetida, Chamomilla, Crocus Sativus, Hyoscyamus Niger, Ignatia Amara, Sumbul, Valeriana Officinalis,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20100825",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories",
"SubstanceName": "ACONITUM NAPELLUS; ASAFETIDA; MATRICARIA RECUTITA; SAFFRON; HYOSCYAMUS NIGER; STRYCHNOS IGNATII SEED; FERULA SUMBUL ROOT; VALERIAN",
"StrengthNumber": "200; 4; 3; 3; 200; 4; 3; 3",
"StrengthUnit": "[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL",
"Status": "Deprecated",
"LastUpdate": "2016-12-02"
},
{
"NDCCode": "50845-0044-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (50845-0044-2) / 30 mL in 1 BOTTLE, SPRAY (50845-0044-1) ",
"NDC11Code": "50845-0044-02",
"ProductNDC": "50845-0044",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Back Pain And Sciatica",
"NonProprietaryName": "Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20110105",
"EndMarketingDate": "20241231",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; ATROPA BELLADONNA; BLACK COHOSH; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RANUNCULUS BULBOSUS WHOLE; TOXICODENDRON PUBESCENS LEAF",
"StrengthNumber": "200; 200; 6; 6; 6; 6; 200; 10; 3; 30; 30; 200",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL",
"Pharm_Classes": "Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
"Status": "Deprecated",
"LastUpdate": "2025-01-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20170125",
"EndMarketingDatePackage": "20241231",
"SamplePackage": "N",
"IndicationAndUsage": "May temporarily relieve these symptoms of back pain and sciatica: 1 lower back pain, 2 muscle cramps, 3 neck and back stiffness, 4 muscle spasms**."
},
{
"NDCCode": "50845-0044-3",
"PackageDescription": "1 CARTON in 1 CARTON (50845-0044-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0044-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0044-1)",
"NDC11Code": "50845-0044-03",
"ProductNDC": "50845-0044",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Back Pain And Sciatica",
"NonProprietaryName": "Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum,",
"DosageFormName": "SPRAY",
"RouteName": "ORAL",
"StartMarketingDate": "20110105",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BLACK COHOSH; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RANUNCULUS BULBOSUS; TOXICODENDRON PUBESCENS LEAF",
"StrengthNumber": "200; 200; 6; 6; 6; 6; 200; 10; 3; 30; 30; 200",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL",
"Status": "Deprecated",
"LastUpdate": "2015-02-27"
},
{
"NDCCode": "50845-0045-2",
"PackageDescription": "1 BOTTLE, SPRAY in 1 CARTON (50845-0045-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0045-1) ",
"NDC11Code": "50845-0045-02",
"ProductNDC": "50845-0045",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Metals",
"NonProprietaryName": "Alumina, Arsenicum Metallicum, Mercurius Corrosivus, Niccolum Metallicum, Plumbum Metallicum, Radium Bromatum, Stannum Metallicum",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20140102",
"EndMarketingDate": "20230731",
"MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
"LabelerName": "Liddell Laboratories, Inc.",
"SubstanceName": "ALUMINUM OXIDE; ARSENIC; LEAD; MERCURIC CHLORIDE; NICKEL; RADIUM BROMIDE; TIN",
"StrengthNumber": "30; 30; 30; 30; 30; 30; 30",
"StrengthUnit": "[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL",
"Pharm_Classes": "Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]",
"Status": "Deprecated",
"LastUpdate": "2023-07-31",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"StartMarketingDatePackage": "20140102",
"EndMarketingDatePackage": "20230731",
"SamplePackage": "N"
}
]
}
{"NDC":[{"NDCCode":"50845-0238-2","ProprietaryName":"Vaccines","NonProprietaryName":"Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens"},{"NDCCode":"50845-0238-1","ProprietaryName":"Vaccines","NonProprietaryName":"Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens"},{"NDCCode":"15631-0238-2","ProprietaryName":"Iridium Metallicum","NonProprietaryName":"Iridium Metallicum"},{"NDCCode":"17856-0238-2","ProprietaryName":"Morphine Sulfate","NonProprietaryName":"Morphine Sulfate"},{"NDCCode":"37662-0238-2","ProprietaryName":"Chelidonium Majus","NonProprietaryName":"Chelidonium Majus"},{"NDCCode":"49288-0238-1","ProprietaryName":"Number Fourteen Grass Mixture","NonProprietaryName":"Number Fourteen Grass Mixture"},{"NDCCode":"49288-0238-2","ProprietaryName":"Number Fourteen Grass Mixture","NonProprietaryName":"Number Fourteen Grass Mixture"},{"NDCCode":"59535-0238-2","ProprietaryName":"Volcanic Grape Callus Mask","NonProprietaryName":"Adenosine, Niacinamide"},{"NDCCode":"62011-0238-2","ProprietaryName":"Pain Reliever Rapid Release","NonProprietaryName":"Acetaminophen"},{"NDCCode":"66406-0238-2","NonProprietaryName":"Droxidopa"},{"NDCCode":"67296-0238-2","ProprietaryName":"Prochlorperazine Maleate","NonProprietaryName":"Prochlorperazine Maleate"},{"NDCCode":"70518-0238-2","ProprietaryName":"Clindamycin Hydrochloride","NonProprietaryName":"Clindamycin Hydrochloride"},{"NDCCode":"71335-0238-2","ProprietaryName":"Citalopram Hydrobromide","NonProprietaryName":"Citalopram Hydrobromide"},{"NDCCode":"79481-0238-2","ProprietaryName":"Oil-free Moisturizer","NonProprietaryName":"Avobenzone, Octisalate, Octocrylene"},{"NDCCode":"50845-0018-2","ProprietaryName":"Acne","NonProprietaryName":"Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuratum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens"},{"NDCCode":"50845-0018-3","ProprietaryName":"Acne","NonProprietaryName":"Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuratum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens"},{"NDCCode":"50845-0021-3","ProprietaryName":"Cough And Bronchial","NonProprietaryName":"Antimonium Tartaricum, Arsenicum Album, Arsenicum Iodatum, Arum Triphyllum, Baptisia Tinctoria, Bryonia, Drosera, Echinacea,"},{"NDCCode":"50845-0031-3","ProprietaryName":"Allergy","NonProprietaryName":"Allium Cepa, Apis Mellifica, Aralia Racemosa, Arundo Mauritanica, Baptisia Tinctoria, Echinacea, Euphrasia Officinalis, Gelsemium Sempervirens,"},{"NDCCode":"50845-0032-2","ProprietaryName":"Jet Lag","NonProprietaryName":"Anacardium Orientale, Apis Mellifica, Carbo Vegetabilis, Carduus Marianus, Cocculus Indicus, Kali Phosphoricum, Nux Vomica, Passiflora Incarnata, Phosphoricum Acidum, Tabacum,"},{"NDCCode":"50845-0032-3","ProprietaryName":"Jet Lag","NonProprietaryName":"Anacardium Orientale, Apis Mellifica, Carbo Vegetabilis, Carduus Marianus, Cocculus Indicus, Kali Phosphoricum, Nux Vomica, Passiflora Incarnata, Phosphoricum Acidum, Tabacum,"},{"NDCCode":"50845-0035-2","ProprietaryName":"Vital Female Sexual Energy","NonProprietaryName":"Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Hypophysis Suis, L-arginine, Lactuca Virosa, Onosmodium Virginianum, Oophorinum Suis, Phosphoricum Acidum, Sepia, Thuja Occidentalis"},{"NDCCode":"50845-0035-3","ProprietaryName":"Vital Female Sexual Energy","NonProprietaryName":"Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Lactuca Virosa, L-arginine,"},{"NDCCode":"50845-0038-3","ProprietaryName":"Vital Male Sexual Energy","NonProprietaryName":"Arnica Montana, Caladium Seguinum, Carduus Marianus, Damiana, Galium Aparine, Glandula Suprarenalis Suis, Hepar Suis, Korean Ginseng,"},{"NDCCode":"50845-0041-3","ProprietaryName":"Vital Hgh","NonProprietaryName":"Hepar Suis, Human Growth Hormone, Pituitary Suis,"},{"NDCCode":"50845-0042-3","ProprietaryName":"Brain Energy","NonProprietaryName":"Arnica Montana, Brain Suis, Carduus Marianus, Cinchona Officinalis, Gingko Biloba, Lecithin, Millefolium, Phosphoricum Acidum,"},{"NDCCode":"50845-0043-2","ProprietaryName":"Anger","NonProprietaryName":"Aconitum Napellus, Asafoetida, Chamomilla, Crocus Sativus, Hyoscyamus Niger, Ignatia Amara, Sumbul, Valeriana Officinalis"},{"NDCCode":"50845-0043-3","ProprietaryName":"Anger","NonProprietaryName":"Aconitum Napellus, Asafoetida, Chamomilla, Crocus Sativus, Hyoscyamus Niger, Ignatia Amara, Sumbul, Valeriana Officinalis,"},{"NDCCode":"50845-0044-2","ProprietaryName":"Back Pain And Sciatica","NonProprietaryName":"Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox"},{"NDCCode":"50845-0044-3","ProprietaryName":"Back Pain And Sciatica","NonProprietaryName":"Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum,"},{"NDCCode":"50845-0045-2","ProprietaryName":"Metals","NonProprietaryName":"Alumina, Arsenicum Metallicum, Mercurius Corrosivus, Niccolum Metallicum, Plumbum Metallicum, Radium Bromatum, Stannum Metallicum"}]}
<?xml version="1.0" encoding="utf-8"?>
<NDCList>
<NDC>
<NDCCode>50845-0238-2</NDCCode>
<PackageDescription>1 BOTTLE, DROPPER in 1 CARTON (50845-0238-2) > 30 mL in 1 BOTTLE, DROPPER (50845-0238-1) </PackageDescription>
<NDC11Code>50845-0238-02</NDC11Code>
<ProductNDC>50845-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Vaccines</ProprietaryName>
<NonProprietaryName>Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20180306</StartMarketingDate>
<EndMarketingDate>20250212</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ARNICA MONTANA; MERCURIC CHLORIDE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAF; URTICA URENS</SubstanceName>
<StrengthNumber>3; 200; 200; 200; 3</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2025-02-13</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20180306</StartMarketingDatePackage>
<EndMarketingDatePackage>20250212</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. Children and adults may expect temporary relief from symptoms such as. minor fever. pain. redness. weakness. lack of energy. swelling**. **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>50845-0238-1</NDCCode>
<PackageDescription>30 mL in 1 BOTTLE, DROPPER (50845-0238-1) </PackageDescription>
<NDC11Code>50845-0238-01</NDC11Code>
<ProductNDC>50845-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Vaccines</ProprietaryName>
<NonProprietaryName>Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20180306</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ARNICA MONTANA; MERCURIC CHLORIDE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAF; URTICA URENS</SubstanceName>
<StrengthNumber>3; 200; 200; 200; 3</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2018-04-01</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20191231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20180306</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
</NDC>
<NDC>
<NDCCode>15631-0238-2</NDCCode>
<PackageDescription>400 PELLET in 1 PACKAGE (15631-0238-2) </PackageDescription>
<NDC11Code>15631-0238-02</NDC11Code>
<ProductNDC>15631-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Iridium Metallicum</ProprietaryName>
<NonProprietaryName>Iridium Metallicum</NonProprietaryName>
<DosageFormName>PELLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20150902</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Rxhomeo Private Limited d.b.a. Rxhomeo, Inc</LabelerName>
<SubstanceName>IRIDIUM</SubstanceName>
<StrengthNumber>3</StrengthNumber>
<StrengthUnit>[hp_X]/1</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2022-01-04</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20211231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20180101</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>Condition listed above or as directed by the physician.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>17856-0238-2</NDCCode>
<PackageDescription>60 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0238-2) / 2.5 mL in 1 CUP, UNIT-DOSE</PackageDescription>
<NDC11Code>17856-0238-02</NDC11Code>
<ProductNDC>17856-0238</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Morphine Sulfate</ProprietaryName>
<NonProprietaryName>Morphine Sulfate</NonProprietaryName>
<DosageFormName>SOLUTION</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20080317</StartMarketingDate>
<MarketingCategoryName>NDA</MarketingCategoryName>
<ApplicationNumber>NDA022195</ApplicationNumber>
<LabelerName>ATLANTIC BIOLOGICALS CORP.</LabelerName>
<SubstanceName>MORPHINE SULFATE</SubstanceName>
<StrengthNumber>20</StrengthNumber>
<StrengthUnit>mg/5mL</StrengthUnit>
<Pharm_Classes>Full Opioid Agonists [MoA], Opioid Agonist [EPC]</Pharm_Classes>
<DEASchedule>CII</DEASchedule>
<Status>Deprecated</Status>
<LastUpdate>2026-01-01</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20251231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20240520</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>Morphine sulfate solution are formulations of morphine, an opioid agonist, indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. Morphine sulfate solution is an opioid analgesic indicated for the relief of moderate to severe acute and chronic pain in opioid-tolerant patients. oral(10 mg per 5 mL and 20 mg per 5 mL)oral100 mg per 5 mL (20 mg/mL). Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL) may cause fatal respiratory depression when administered to patients not previously exposed to opioids. Patients considered to be opioid tolerant are those who are taking at least 60 mg oral morphine per day, or at least 30 mg of oral oxycodone per day, or at least 12 mg hydromorphone per day, or an equianalgesic dose of another opioid, for a week or longer.</IndicationAndUsage>
<Description>Chemically, morphine sulfate is 7,8-didehydro-4,5 alpha-epoxy-17 methyl-morphinan-3,6 alpha-diol sulfate (2:1) (salt) pentahydrate with a molecular mass of 758. Morphine sulfate occurs as white, feathery, silky crystals; cubical masses of crystal; or white crystalline powder. It is soluble in water anlightly soluble in alcohol, but is practically insoluble in chloroform or ether. The octanol:water partition coefficient of morphine is 1.42 at physiologic pH and the pKa is 7.9 for the tertiary nitrogen (the majority is ionized at pH 7.4). For the 10 mg and 20 mg per 5 mL strengths: Each 5 mL of oral solution contains 10 or 20 mg of morphine sulfate USP and the following inactive ingredients: citric acid, edetate disodium, FD&C Green No. 3 (fast green), glycerin, methylparaben (only in 20 mg/5 mL concentration), propylparaben (only in 20 mg/5 mL concentration), sodium benzoate, sorbitol and water. For the 100 mg per 5 mL (20 mg/mL) strength: Each 5 mL of oral solution contains 100 mg of morphine sulfate USP and the following inactive ingredients: citric acid, edetate disodium, glycerin, sodium benzoate, sorbitol, and water. Additionally, the tinted solution contains D & C Red No. 33 and sucralose.</Description>
</NDC>
<NDC>
<NDCCode>37662-0238-2</NDCCode>
<PackageDescription>500 PELLET in 1 VIAL, GLASS (37662-0238-2) </PackageDescription>
<NDC11Code>37662-0238-02</NDC11Code>
<ProductNDC>37662-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Chelidonium Majus</ProprietaryName>
<NonProprietaryName>Chelidonium Majus</NonProprietaryName>
<DosageFormName>PELLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20220531</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Hahnemann Laboratories, INC.</LabelerName>
<SubstanceName>CHELIDONIUM MAJUS</SubstanceName>
<StrengthNumber>200</StrengthNumber>
<StrengthUnit>[hp_C]/1</StrengthUnit>
<Status>Active</Status>
<LastUpdate>2022-06-02</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20220531</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
</NDC>
<NDC>
<NDCCode>49288-0238-1</NDCCode>
<PackageDescription>2 mL in 1 VIAL, MULTI-DOSE (49288-0238-1)</PackageDescription>
<NDC11Code>49288-0238-01</NDC11Code>
<ProductNDC>49288-0238</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Number Fourteen Grass Mixture</ProprietaryName>
<NonProprietaryName>Number Fourteen Grass Mixture</NonProprietaryName>
<DosageFormName>INJECTION, SOLUTION</DosageFormName>
<RouteName>INTRADERMAL; SUBCUTANEOUS</RouteName>
<StartMarketingDate>19970613</StartMarketingDate>
<MarketingCategoryName>BLA</MarketingCategoryName>
<ApplicationNumber>BLA102223</ApplicationNumber>
<LabelerName>Antigen Laboratories, Inc.</LabelerName>
<SubstanceName>POA COMPRESSA POLLEN; TYPHA LATIFOLIA POLLEN; BROMUS SECALINUS POLLEN; ZEA MAYS POLLEN; SECALE CEREALE POLLEN; TRITICUM AESTIVUM POLLEN; SORGHUM HALEPENSE POLLEN; ELYMUS REPENS POLLEN; PHALARIS ARUNDINACEA POLLEN; BROMUS INERMIS POLLEN; SORGHUM BICOLOR SSP. DRUMMONDII POLLEN; ARRHENATHERUM ELATIUS POLLEN; HOLCUS LANATUS POLLEN; PASCOPYRUM SMITHII POLLEN</SubstanceName>
<StrengthNumber>.0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036</StrengthNumber>
<StrengthUnit>g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL</StrengthUnit>
<Pharm_Classes>Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]</Pharm_Classes>
<Status>Deprecated</Status>
<LastUpdate>2019-09-21</LastUpdate>
<ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
<IndicationAndUsage>Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.</IndicationAndUsage>
<Description>Antigen Laboratories’ allergenic extracts are manufactured from source material listed on the vial label. Lower concentrations (e.g. 1:50, 1:33, etc.) may be prepared either by dilution from a more concentrated stock or by direct extraction. The extract is a sterile solution containing extractables of source materials obtained from biological collecting and/or processing firms and Antigen Laboratories. All source materials are inspected by Antigen Laboratories’ technical personnel in accordance with 21 CFR 680.1 (b) (1). The route of administration for immunotherapy is subcutaneous. The routes of administration for diagnostic purposes are intradermal or prick-puncture of the skin. FOR ALLERGENIC EXTRACTS CONTAINING 50% V/V GLYCERINE AS PRESERVATIVE AND STABILIZER. INACTIVE INGREDIENTS. Sodium chloride…………………………………………………………….0.95%. Sodium bicarbonate………………………………………………………..0.24%. Glycerine…………………………………………………………………50% (v/v). Water for Injection…………………………………………………q.s. to volume. Active allergens are described by common and scientific name on the stock concentrate container label or on last page of this circular. Food allergenic extracts may be manufactured on a weight/volume (w/v) or volume/volume (v/v) basis. Food extracts made from dried raw material are extracted at 2-10% (1:50-1:10 w/v ratio) in extracting fluid containing 50% glycerine. Slurries of juicy fruits or vegetables (prepared with a minimum amount of water for injection) are combined with an equal volume of glycerine for a ration of 1:1 volume/volume (v/v). Sodium chloride and sodium bicarbonate are added to the slurry and glycerine mixture. Fresh egg white extract is prepared by adding one part raw egg white to nine parts of extracting fluid (1:9 v/v). Antigen E is considered the most important allergen of Short Ragweed pollen and is used for the standardization of Short Ragweed allergenic extracts. Stock mixtures containing Short Ragweed are analyzed for Antigen E content by radial immunodiffusion using Center for Biologics Evaluation and Research (CBER) references and anti-serum. Antigen E content expressed as units of Antigen E per milliliter (U/ml) is printed on container label.</Description>
</NDC>
<NDC>
<NDCCode>49288-0238-2</NDCCode>
<PackageDescription>5 mL in 1 VIAL, MULTI-DOSE (49288-0238-2)</PackageDescription>
<NDC11Code>49288-0238-02</NDC11Code>
<ProductNDC>49288-0238</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Number Fourteen Grass Mixture</ProprietaryName>
<NonProprietaryName>Number Fourteen Grass Mixture</NonProprietaryName>
<DosageFormName>INJECTION, SOLUTION</DosageFormName>
<RouteName>INTRADERMAL; SUBCUTANEOUS</RouteName>
<StartMarketingDate>19970613</StartMarketingDate>
<MarketingCategoryName>BLA</MarketingCategoryName>
<ApplicationNumber>BLA102223</ApplicationNumber>
<LabelerName>Antigen Laboratories, Inc.</LabelerName>
<SubstanceName>POA COMPRESSA POLLEN; TYPHA LATIFOLIA POLLEN; BROMUS SECALINUS POLLEN; ZEA MAYS POLLEN; SECALE CEREALE POLLEN; TRITICUM AESTIVUM POLLEN; SORGHUM HALEPENSE POLLEN; ELYMUS REPENS POLLEN; PHALARIS ARUNDINACEA POLLEN; BROMUS INERMIS POLLEN; SORGHUM BICOLOR SSP. DRUMMONDII POLLEN; ARRHENATHERUM ELATIUS POLLEN; HOLCUS LANATUS POLLEN; PASCOPYRUM SMITHII POLLEN</SubstanceName>
<StrengthNumber>.0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036; .0036</StrengthNumber>
<StrengthUnit>g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL</StrengthUnit>
<Pharm_Classes>Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Cell-mediated Immunity [PE],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]</Pharm_Classes>
<Status>Deprecated</Status>
<LastUpdate>2019-09-21</LastUpdate>
<ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
<IndicationAndUsage>Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.</IndicationAndUsage>
<Description>Antigen Laboratories’ allergenic extracts are manufactured from source material listed on the vial label. Lower concentrations (e.g. 1:50, 1:33, etc.) may be prepared either by dilution from a more concentrated stock or by direct extraction. The extract is a sterile solution containing extractables of source materials obtained from biological collecting and/or processing firms and Antigen Laboratories. All source materials are inspected by Antigen Laboratories’ technical personnel in accordance with 21 CFR 680.1 (b) (1). The route of administration for immunotherapy is subcutaneous. The routes of administration for diagnostic purposes are intradermal or prick-puncture of the skin. FOR ALLERGENIC EXTRACTS CONTAINING 50% V/V GLYCERINE AS PRESERVATIVE AND STABILIZER. INACTIVE INGREDIENTS. Sodium chloride…………………………………………………………….0.95%. Sodium bicarbonate………………………………………………………..0.24%. Glycerine…………………………………………………………………50% (v/v). Water for Injection…………………………………………………q.s. to volume. Active allergens are described by common and scientific name on the stock concentrate container label or on last page of this circular. Food allergenic extracts may be manufactured on a weight/volume (w/v) or volume/volume (v/v) basis. Food extracts made from dried raw material are extracted at 2-10% (1:50-1:10 w/v ratio) in extracting fluid containing 50% glycerine. Slurries of juicy fruits or vegetables (prepared with a minimum amount of water for injection) are combined with an equal volume of glycerine for a ration of 1:1 volume/volume (v/v). Sodium chloride and sodium bicarbonate are added to the slurry and glycerine mixture. Fresh egg white extract is prepared by adding one part raw egg white to nine parts of extracting fluid (1:9 v/v). Antigen E is considered the most important allergen of Short Ragweed pollen and is used for the standardization of Short Ragweed allergenic extracts. Stock mixtures containing Short Ragweed are analyzed for Antigen E content by radial immunodiffusion using Center for Biologics Evaluation and Research (CBER) references and anti-serum. Antigen E content expressed as units of Antigen E per milliliter (U/ml) is printed on container label.</Description>
</NDC>
<NDC>
<NDCCode>59535-0238-2</NDCCode>
<PackageDescription>5 POUCH in 1 PACKAGE (59535-0238-2) > 20 g in 1 POUCH (59535-0238-1)</PackageDescription>
<NDC11Code>59535-0238-02</NDC11Code>
<ProductNDC>59535-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Volcanic Grape Callus Mask</ProprietaryName>
<NonProprietaryName>Adenosine, Niacinamide</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>TOPICAL</RouteName>
<StartMarketingDate>20160801</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED DRUG OTHER</MarketingCategoryName>
<LabelerName>AMI Cosmetic Co.,Ltd.</LabelerName>
<SubstanceName>NIACINAMIDE; ADENOSINE</SubstanceName>
<StrengthNumber>2; .04</StrengthNumber>
<StrengthUnit>g/100g; g/100g</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-01-18</LastUpdate>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20191231</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>62011-0238-2</NDCCode>
<PackageDescription>1 BOTTLE, PLASTIC in 1 CARTON (62011-0238-2) / 24 TABLET, COATED in 1 BOTTLE, PLASTIC</PackageDescription>
<NDC11Code>62011-0238-02</NDC11Code>
<ProductNDC>62011-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Pain Reliever Rapid Release</ProprietaryName>
<NonProprietaryName>Acetaminophen</NonProprietaryName>
<DosageFormName>TABLET, COATED</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20141024</StartMarketingDate>
<EndMarketingDate>20260131</EndMarketingDate>
<MarketingCategoryName>OTC MONOGRAPH DRUG</MarketingCategoryName>
<ApplicationNumber>M013</ApplicationNumber>
<LabelerName>Strategic Sourcing Services LLC</LabelerName>
<SubstanceName>ACETAMINOPHEN</SubstanceName>
<StrengthNumber>500</StrengthNumber>
<StrengthUnit>mg/1</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2026-02-02</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20180301</StartMarketingDatePackage>
<EndMarketingDatePackage>20260131</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>temporarily relieves minor aches and pains due to: the common coldheadachebackacheminor pain of arthritistoothachemuscular achespremenstrual and menstrual cramps. temporarily reduces fever.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>66406-0238-2</NDCCode>
<PackageDescription>24 BOTTLE in 1 CASE (66406-0238-2) > 90 CAPSULE in 1 BOTTLE</PackageDescription>
<NDC11Code>66406-0238-02</NDC11Code>
<ProductNDC>66406-0238</ProductNDC>
<ProductTypeName>DRUG FOR FURTHER PROCESSING</ProductTypeName>
<NonProprietaryName>Droxidopa</NonProprietaryName>
<DosageFormName>CAPSULE</DosageFormName>
<StartMarketingDate>20140901</StartMarketingDate>
<EndMarketingDate>20180117</EndMarketingDate>
<MarketingCategoryName>DRUG FOR FURTHER PROCESSING</MarketingCategoryName>
<LabelerName>Patheon Inc.</LabelerName>
<SubstanceName>DROXIDOPA</SubstanceName>
<StrengthNumber>100</StrengthNumber>
<StrengthUnit>mg/1</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2014-02-04</LastUpdate>
<ListingRecordCertifiedThrough>20180117</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>67296-0238-2</NDCCode>
<PackageDescription>15 TABLET in 1 BOTTLE (67296-0238-2) </PackageDescription>
<NDC11Code>67296-0238-02</NDC11Code>
<ProductNDC>67296-0238</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Prochlorperazine Maleate</ProprietaryName>
<NonProprietaryName>Prochlorperazine Maleate</NonProprietaryName>
<DosageFormName>TABLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20010101</StartMarketingDate>
<MarketingCategoryName>ANDA</MarketingCategoryName>
<ApplicationNumber>ANDA040268</ApplicationNumber>
<LabelerName>RedPharm Drug, Inc.</LabelerName>
<SubstanceName>PROCHLORPERAZINE MALEATE</SubstanceName>
<StrengthNumber>10</StrengthNumber>
<StrengthUnit>mg/1</StrengthUnit>
<Pharm_Classes>Phenothiazine [EPC], Phenothiazines [CS]</Pharm_Classes>
<Status>Deprecated</Status>
<LastUpdate>2026-01-01</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20251231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20010101</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>For control of severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. However, prochlorperazine is not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). When used in the treatment of non-psychotic anxiety, prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see WARNINGS). The effectiveness of prochlorperazine as treatment for non-psychotic anxiety was established in 4-week clinical studies of outpatients with generalized anxiety disorder. This evidence does not predict that prochlorperazine will be useful in patients with other non-psychotic conditions in which anxiety, or signs that mimic anxiety, are found (e.g., physical illness, organic mental conditions, agitated depression, character pathologies, etc.). Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.</IndicationAndUsage>
<Description>Prochlorperazine is a phenothiazine derivative, present in prochlorperazine tablets as the maleate. Prochlorperazine maleate is designated chemically as 2-chloro-10-[3-(4- methyl-1 -piperazinyl)propyl] phenothiazine maleate [molecular weight 606.10] and has the following structure. [Structure of Prochlorperazine]. Prochlorperazine Maleate is classified as an anti-emetic and antipsychotic agent. Prochlorperazine maleate is white or pale yellow, practically odorless crystalline powder. It is practically insoluble in water and in alcohol; slightly soluble in warm chloroform. Each tablet, for oral administration contains prochlorperazine maleate equivalent to 5 mg or 10 mg of prochlorperazine. In addition, each tablet contains the following inactive ingredients: D&C yellow no. 10 aluminum lake, FD&C blue no. 2 aluminum lake, FD&C yellow no. 6 aluminum lake, hydroxypropyl methylcellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, pregelatinized starch, stearic acid and titanium dioxide.</Description>
</NDC>
<NDC>
<NDCCode>70518-0238-2</NDCCode>
<PackageDescription>30 CAPSULE in 1 BOTTLE, PLASTIC (70518-0238-2) </PackageDescription>
<NDC11Code>70518-0238-02</NDC11Code>
<ProductNDC>70518-0238</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Clindamycin Hydrochloride</ProprietaryName>
<NonProprietaryName>Clindamycin Hydrochloride</NonProprietaryName>
<DosageFormName>CAPSULE</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20170220</StartMarketingDate>
<MarketingCategoryName>ANDA</MarketingCategoryName>
<ApplicationNumber>ANDA063029</ApplicationNumber>
<LabelerName>REMEDYREPACK INC.</LabelerName>
<SubstanceName>CLINDAMYCIN HYDROCHLORIDE</SubstanceName>
<StrengthNumber>300</StrengthNumber>
<StrengthUnit>mg/1</StrengthUnit>
<Pharm_Classes>Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]</Pharm_Classes>
<Status>Deprecated</Status>
<LastUpdate>2019-12-24</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20201231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20170419</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
</NDC>
<NDC>
<NDCCode>71335-0238-2</NDCCode>
<PackageDescription>60 TABLET in 1 BOTTLE (71335-0238-2) </PackageDescription>
<NDC11Code>71335-0238-02</NDC11Code>
<ProductNDC>71335-0238</ProductNDC>
<ProductTypeName>HUMAN PRESCRIPTION DRUG</ProductTypeName>
<ProprietaryName>Citalopram Hydrobromide</ProprietaryName>
<NonProprietaryName>Citalopram Hydrobromide</NonProprietaryName>
<DosageFormName>TABLET</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20071018</StartMarketingDate>
<MarketingCategoryName>ANDA</MarketingCategoryName>
<ApplicationNumber>ANDA078216</ApplicationNumber>
<LabelerName>Bryant Ranch Prepack</LabelerName>
<SubstanceName>CITALOPRAM HYDROBROMIDE</SubstanceName>
<StrengthNumber>20</StrengthNumber>
<StrengthUnit>mg/1</StrengthUnit>
<Pharm_Classes>Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2024-11-13</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20180919</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14)] .</IndicationAndUsage>
<Description>Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (±)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3dihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula. The molecular formula is C 20H 22BrFN 2O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder. Citalopram hydrobromide is sparingly soluble in water and soluble in ethanol. Citalopram, USP 10 mg tablets are film-coated, round shaped tablets containing citalopram hydrobromide in strengths equivalent to 10 mg citalopram base. Citalopram hydrobromide, USP 20 mg and 40 mg tablets are film-coated, oval shaped, scored tablets containing citalopram hydrobromide, in strengths equivalent to 20 mg or 40 mg citalopram base. The tablets also contain the following inactive ingredients: copovidone, corn starch, croscarmellose sodium, ferric oxide red, ferric oxide yellow, glycerin, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, and titanium dioxide.</Description>
</NDC>
<NDC>
<NDCCode>79481-0238-2</NDCCode>
<PackageDescription>118 mL in 1 BOTTLE, PLASTIC (79481-0238-2) </PackageDescription>
<NDC11Code>79481-0238-02</NDC11Code>
<ProductNDC>79481-0238</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Oil-free Moisturizer</ProprietaryName>
<NonProprietaryName>Avobenzone, Octisalate, Octocrylene</NonProprietaryName>
<DosageFormName>LOTION</DosageFormName>
<RouteName>TOPICAL</RouteName>
<StartMarketingDate>20200315</StartMarketingDate>
<MarketingCategoryName>OTC MONOGRAPH DRUG</MarketingCategoryName>
<ApplicationNumber>M020</ApplicationNumber>
<LabelerName>Meijer Distribution, Inc.</LabelerName>
<SubstanceName>AVOBENZONE; OCTISALATE; OCTOCRYLENE</SubstanceName>
<StrengthNumber>30; 50; 50</StrengthNumber>
<StrengthUnit>mg/mL; mg/mL; mg/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2025-04-18</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20251231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20200315</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>■ helps prevent sunburn ■ if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>50845-0018-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (50845-0018-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0018-1)</PackageDescription>
<NDC11Code>50845-0018-02</NDC11Code>
<ProductNDC>50845-0018</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Acne</ProprietaryName>
<NonProprietaryName>Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuratum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20110120</StartMarketingDate>
<EndMarketingDate>20190326</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; ANTIMONY TRISULFIDE; CENTELLA ASIATICA; JUGLANS REGIA FLOWERING TOP; POTASSIUM BROMIDE; LEDUM PALUSTRE TWIG; SODIUM SULFIDE NONAHYDRATE; RANCID BEEF; RADIUM BROMIDE; SANGUINARIA CANADENSIS ROOT; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS</SubstanceName>
<StrengthNumber>200; 30; 30; 6; 30; 6; 200; 30; 200; 3; 200; 200; 3</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-03-27</LastUpdate>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
</NDC>
<NDC>
<NDCCode>50845-0018-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0018-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0018-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0018-1)</PackageDescription>
<NDC11Code>50845-0018-03</NDC11Code>
<ProductNDC>50845-0018</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Acne</ProprietaryName>
<NonProprietaryName>Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuratum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20110120</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; ANTIMONY TRISULFIDE; CENTELLA ASIATICA; JUGLANS REGIA FLOWERING TOP; POTASSIUM BROMIDE; LEDUM PALUSTRE TWIG; SODIUM SULFIDE NONAHYDRATE; RANCID BEEF; RADIUM BROMIDE; SANGUINARIA CANADENSIS ROOT; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS</SubstanceName>
<StrengthNumber>200; 30; 30; 6; 30; 6; 200; 30; 200; 3; 200; 200; 3</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2016-12-02</LastUpdate>
</NDC>
<NDC>
<NDCCode>50845-0021-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0021-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0021-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0021-1)</PackageDescription>
<NDC11Code>50845-0021-03</NDC11Code>
<ProductNDC>50845-0021</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Cough And Bronchial</ProprietaryName>
<NonProprietaryName>Antimonium Tartaricum, Arsenicum Album, Arsenicum Iodatum, Arum Triphyllum, Baptisia Tinctoria, Bryonia, Drosera, Echinacea,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100902</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories</LabelerName>
<SubstanceName>ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ARSENIC TRIIODIDE; ARISAEMA TRIPHYLLUM ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; ECHINACEA; EUPATORIUM PERFOLIATUM FLOWERING TOP; POTASSIUM BROMIDE; SUS SCROFA LUNG; MERCURIC CHLORIDE; LOBARIA PULMONARIA; SULFUR IODIDE; URTICA URENS</SubstanceName>
<StrengthNumber>200; 200; 200; 30; 3; 200; 30; 3; 200; 6; 6; 200; 200; 200; 200</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-02-06</LastUpdate>
<ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>50845-0031-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0031-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0031-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0031-1)</PackageDescription>
<NDC11Code>50845-0031-03</NDC11Code>
<ProductNDC>50845-0031</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Allergy</ProprietaryName>
<NonProprietaryName>Allium Cepa, Apis Mellifica, Aralia Racemosa, Arundo Mauritanica, Baptisia Tinctoria, Echinacea, Euphrasia Officinalis, Gelsemium Sempervirens,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100812</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories</LabelerName>
<SubstanceName>ONION; APIS MELLIFERA; ARALIA RACEMOSA ROOT; ARUNDO PLINIANA ROOT; BAPTISIA TINCTORIA ROOT; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; TOXICODENDRON PUBESCENS LEAF; SCHOENOCAULON OFFICINALE SEED; SANGUINARIA CANADENSIS ROOT; URTICA URENS</SubstanceName>
<StrengthNumber>6; 3; 6; 30; 3; 4; 6; 200; 12; 6; 200; 6; 200; 200</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-01-22</LastUpdate>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20191231</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>50845-0032-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (50845-0032-2) / 30 mL in 1 BOTTLE, SPRAY (50845-0032-1) </PackageDescription>
<NDC11Code>50845-0032-02</NDC11Code>
<ProductNDC>50845-0032</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Jet Lag</ProprietaryName>
<NonProprietaryName>Anacardium Orientale, Apis Mellifica, Carbo Vegetabilis, Carduus Marianus, Cocculus Indicus, Kali Phosphoricum, Nux Vomica, Passiflora Incarnata, Phosphoricum Acidum, Tabacum,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20110602</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>SEMECARPUS ANACARDIUM JUICE; APIS MELLIFERA; ACTIVATED CHARCOAL; SILYBUM MARIANUM SEED; ANAMIRTA COCCULUS SEED; POTASSIUM PHOSPHATE, DIBASIC; STRYCHNOS NUX-VOMICA SEED; PASSIFLORA INCARNATA TOP; PHOSPHORIC ACID; TOBACCO LEAF</SubstanceName>
<StrengthNumber>12; 200; 200; 3; 30; 12; 30; 1; 200; 6</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Pharm_Classes>Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]</Pharm_Classes>
<Status>Active</Status>
<LastUpdate>2024-05-23</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20261231</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>20161101</StartMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>For use during and after jet travel as it may help temporarily relieve the symptoms commonly known as "jet lag", such as tiredness, feelings of disorientation, dehydration, and sleeplessness.**. **Claims based upon traditional homeopathic practice, not accepted medical evidence. Not FDA Evaluated.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>50845-0032-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0032-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0032-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0032-1)</PackageDescription>
<NDC11Code>50845-0032-03</NDC11Code>
<ProductNDC>50845-0032</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Jet Lag</ProprietaryName>
<NonProprietaryName>Anacardium Orientale, Apis Mellifica, Carbo Vegetabilis, Carduus Marianus, Cocculus Indicus, Kali Phosphoricum, Nux Vomica, Passiflora Incarnata, Phosphoricum Acidum, Tabacum,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20110602</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; APIS MELLIFERA; PASSIFLORA INCARNATA TOP; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SEMECARPUS ANACARDIUM JUICE; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF</SubstanceName>
<StrengthNumber>200; 30; 200; 1; 200; 12; 12; 3; 30; 6</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2015-01-16</LastUpdate>
</NDC>
<NDC>
<NDCCode>50845-0035-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (50845-0035-2) / 30 mL in 1 BOTTLE, SPRAY (50845-0035-1) </PackageDescription>
<NDC11Code>50845-0035-02</NDC11Code>
<ProductNDC>50845-0035</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Vital Female Sexual Energy</ProprietaryName>
<NonProprietaryName>Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Hypophysis Suis, L-arginine, Lactuca Virosa, Onosmodium Virginianum, Oophorinum Suis, Phosphoricum Acidum, Sepia, Thuja Occidentalis</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100810</StartMarketingDate>
<EndMarketingDate>20241221</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ARGININE; ARNICA MONTANA WHOLE; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; LACTUCA VIROSA WHOLE; ONOSMODIUM VIRGINIANUM WHOLE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND, POSTERIOR; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG</SubstanceName>
<StrengthNumber>6; 3; 6; 3; 3; 3; 30; 200; 30; 30; 12; 30; 1</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2024-12-27</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20160421</StartMarketingDatePackage>
<EndMarketingDatePackage>20241221</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May temporarily relieve symptoms of low female sexual energy, which may include. decrease in sexual desire. decrease in responsiveness and enjoyment. feelings of fatigue**. **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>50845-0035-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0035-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0035-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0035-1)</PackageDescription>
<NDC11Code>50845-0035-03</NDC11Code>
<ProductNDC>50845-0035</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Vital Female Sexual Energy</ProprietaryName>
<NonProprietaryName>Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Lactuca Virosa, L-arginine,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100810</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ARGININE; ARNICA MONTANA; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; LACTUCA VIROSA; ONOSMODIUM VIRGINIANUM WHOLE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG</SubstanceName>
<StrengthNumber>6; 3; 6; 3; 3; 3; 30; 200; 30; 30; 12; 30; 1</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2015-01-02</LastUpdate>
</NDC>
<NDC>
<NDCCode>50845-0038-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0038-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0038-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0038-1)</PackageDescription>
<NDC11Code>50845-0038-03</NDC11Code>
<ProductNDC>50845-0038</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Vital Male Sexual Energy</ProprietaryName>
<NonProprietaryName>Arnica Montana, Caladium Seguinum, Carduus Marianus, Damiana, Galium Aparine, Glandula Suprarenalis Suis, Hepar Suis, Korean Ginseng,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100810</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc</LabelerName>
<SubstanceName>ARNICA MONTANA; DIEFFENBACHIA SEGUINE; SILYBUM MARIANUM SEED; TURNERA DIFFUSA LEAFY TWIG; GALIUM APARINE; SUS SCROFA ADRENAL GLAND; PORK LIVER; ASIAN GINSENG; PHOSPHORIC ACID; SUS SCROFA PITUITARY GLAND; POPULUS TREMULOIDES BARK; TESTOSTERONE; THUJA OCCIDENTALIS LEAFY TWIG; SUS SCROFA THYMUS; SUS SCROFA THYROID; SUS SCROFA TESTICLE; LACTUCA VIROSA; NUPHAR LUTEUM ROOT</SubstanceName>
<StrengthNumber>3; 6; 3; 1; 3; 12; 6; 1; 200; 12; 1; 30; 200; 6; 12; 6; 3; 2</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-02-06</LastUpdate>
<ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>50845-0041-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0041-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0041-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0041-1)</PackageDescription>
<NDC11Code>50845-0041-03</NDC11Code>
<ProductNDC>50845-0041</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Vital Hgh</ProprietaryName>
<NonProprietaryName>Hepar Suis, Human Growth Hormone, Pituitary Suis,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100812</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories</LabelerName>
<SubstanceName>PORK LIVER; SOMATROPIN; SUS SCROFA PITUITARY GLAND</SubstanceName>
<StrengthNumber>6; 30; 30</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2019-02-06</LastUpdate>
<ProductNdcExcludeFlag>E</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>20171231</ListingRecordCertifiedThrough>
</NDC>
<NDC>
<NDCCode>50845-0042-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0042-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0042-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0042-1) </PackageDescription>
<NDC11Code>50845-0042-03</NDC11Code>
<ProductNDC>50845-0042</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Brain Energy</ProprietaryName>
<NonProprietaryName>Arnica Montana, Brain Suis, Carduus Marianus, Cinchona Officinalis, Gingko Biloba, Lecithin, Millefolium, Phosphoricum Acidum,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100928</StartMarketingDate>
<EndMarketingDate>20220930</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories</LabelerName>
<SubstanceName>ACHILLEA MILLEFOLIUM; ARNICA MONTANA; CINCHONA OFFICINALIS BARK; EGG PHOSPHOLIPIDS; GINKGO; PHOSPHORIC ACID; PORK BRAIN; SILYBUM MARIANUM SEED</SubstanceName>
<StrengthNumber>3; 3; 6; 12; 6; 30; 6; 3</StrengthNumber>
<StrengthUnit>[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2022-10-01</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20100928</StartMarketingDatePackage>
<EndMarketingDatePackage>20220930</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
</NDC>
<NDC>
<NDCCode>50845-0043-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (50845-0043-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0043-1) </PackageDescription>
<NDC11Code>50845-0043-02</NDC11Code>
<ProductNDC>50845-0043</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Anger</ProprietaryName>
<NonProprietaryName>Aconitum Napellus, Asafoetida, Chamomilla, Crocus Sativus, Hyoscyamus Niger, Ignatia Amara, Sumbul, Valeriana Officinalis</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100825</StartMarketingDate>
<EndMarketingDate>20240321</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories</LabelerName>
<SubstanceName>ACONITUM NAPELLUS; ASAFETIDA; FERULA SUMBUL ROOT; HYOSCYAMUS NIGER; MATRICARIA RECUTITA; SAFFRON; STRYCHNOS IGNATII SEED; VALERIAN</SubstanceName>
<StrengthNumber>200; 4; 3; 200; 3; 3; 4; 3</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2024-03-22</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20160526</StartMarketingDatePackage>
<EndMarketingDatePackage>20240321</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May temporarily relieve symptoms of anger, such as: 1 explosive outbursts, 2 feelings of hostility, 3 restlessness, 4 irritability.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>50845-0043-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0043-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0043-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0043-1)</PackageDescription>
<NDC11Code>50845-0043-03</NDC11Code>
<ProductNDC>50845-0043</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Anger</ProprietaryName>
<NonProprietaryName>Aconitum Napellus, Asafoetida, Chamomilla, Crocus Sativus, Hyoscyamus Niger, Ignatia Amara, Sumbul, Valeriana Officinalis,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20100825</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories</LabelerName>
<SubstanceName>ACONITUM NAPELLUS; ASAFETIDA; MATRICARIA RECUTITA; SAFFRON; HYOSCYAMUS NIGER; STRYCHNOS IGNATII SEED; FERULA SUMBUL ROOT; VALERIAN</SubstanceName>
<StrengthNumber>200; 4; 3; 3; 200; 4; 3; 3</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2016-12-02</LastUpdate>
</NDC>
<NDC>
<NDCCode>50845-0044-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (50845-0044-2) / 30 mL in 1 BOTTLE, SPRAY (50845-0044-1) </PackageDescription>
<NDC11Code>50845-0044-02</NDC11Code>
<ProductNDC>50845-0044</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Back Pain And Sciatica</ProprietaryName>
<NonProprietaryName>Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20110105</StartMarketingDate>
<EndMarketingDate>20241231</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; ATROPA BELLADONNA; BLACK COHOSH; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RANUNCULUS BULBOSUS WHOLE; TOXICODENDRON PUBESCENS LEAF</SubstanceName>
<StrengthNumber>200; 200; 6; 6; 6; 6; 200; 10; 3; 30; 30; 200</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL</StrengthUnit>
<Pharm_Classes>Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]</Pharm_Classes>
<Status>Deprecated</Status>
<LastUpdate>2025-01-01</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20170125</StartMarketingDatePackage>
<EndMarketingDatePackage>20241231</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
<IndicationAndUsage>May temporarily relieve these symptoms of back pain and sciatica: 1 lower back pain, 2 muscle cramps, 3 neck and back stiffness, 4 muscle spasms**.</IndicationAndUsage>
</NDC>
<NDC>
<NDCCode>50845-0044-3</NDCCode>
<PackageDescription>1 CARTON in 1 CARTON (50845-0044-3) > 1 BOTTLE, SPRAY in 1 CARTON (50845-0044-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0044-1)</PackageDescription>
<NDC11Code>50845-0044-03</NDC11Code>
<ProductNDC>50845-0044</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Back Pain And Sciatica</ProprietaryName>
<NonProprietaryName>Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum,</NonProprietaryName>
<DosageFormName>SPRAY</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20110105</StartMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BLACK COHOSH; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RANUNCULUS BULBOSUS; TOXICODENDRON PUBESCENS LEAF</SubstanceName>
<StrengthNumber>200; 200; 6; 6; 6; 6; 200; 10; 3; 30; 30; 200</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL</StrengthUnit>
<Status>Deprecated</Status>
<LastUpdate>2015-02-27</LastUpdate>
</NDC>
<NDC>
<NDCCode>50845-0045-2</NDCCode>
<PackageDescription>1 BOTTLE, SPRAY in 1 CARTON (50845-0045-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0045-1) </PackageDescription>
<NDC11Code>50845-0045-02</NDC11Code>
<ProductNDC>50845-0045</ProductNDC>
<ProductTypeName>HUMAN OTC DRUG</ProductTypeName>
<ProprietaryName>Metals</ProprietaryName>
<NonProprietaryName>Alumina, Arsenicum Metallicum, Mercurius Corrosivus, Niccolum Metallicum, Plumbum Metallicum, Radium Bromatum, Stannum Metallicum</NonProprietaryName>
<DosageFormName>LIQUID</DosageFormName>
<RouteName>ORAL</RouteName>
<StartMarketingDate>20140102</StartMarketingDate>
<EndMarketingDate>20230731</EndMarketingDate>
<MarketingCategoryName>UNAPPROVED HOMEOPATHIC</MarketingCategoryName>
<LabelerName>Liddell Laboratories, Inc.</LabelerName>
<SubstanceName>ALUMINUM OXIDE; ARSENIC; LEAD; MERCURIC CHLORIDE; NICKEL; RADIUM BROMIDE; TIN</SubstanceName>
<StrengthNumber>30; 30; 30; 30; 30; 30; 30</StrengthNumber>
<StrengthUnit>[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL</StrengthUnit>
<Pharm_Classes>Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]</Pharm_Classes>
<Status>Deprecated</Status>
<LastUpdate>2023-07-31</LastUpdate>
<PackageNdcExcludeFlag>N</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>N</ProductNdcExcludeFlag>
<StartMarketingDatePackage>20140102</StartMarketingDatePackage>
<EndMarketingDatePackage>20230731</EndMarketingDatePackage>
<SamplePackage>N</SamplePackage>
</NDC>
</NDCList>